General Description

Centessa Pharmaceuticals

Youtube Subscribe

Ticker: CNTA

Sector: Biotechnology

Centessa Pharmaceuticals plc has a 1-year low of $3.00 and a 1 year high of $8.65. Centessa focused on asset-centric, patient-centric drug development. The word on The Street.

Extended Summary

Centessa Pharmaceuticals

Centessa Pharmaceuticals plc has a 1-year low of $3.00 and a 1 year high of $8.65. The company last issued its quarterly earnings data on Monday, August 14th. Centessa Pharmaceuticals ( NASDAQ:CNTA – Get Free Report ) last issued its quarterly earnings data on Monday, August 14th. Analysts expect that Centessa. Pharmaceuticals plc will post -1.74 EPS for the current year. Centessa focused on asset-centric, patient-centric drug development. BMO Capital analyst Kostas Biliouris maintained a Buy rating on Centessa Pharmaceuticals today and set a price target of $15.00. The word on The Street in general, suggests a Moderate Buy analyst consensus rating.

Related Results

September 25, 2023 22:36 (London Time)